| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $130.1M | +90.7% |
| SG&A Expense | $37.5M | +99.0% |
| Operating Income | -$165.7M | -90.3% |
| Pre-tax Income | -$157.3M | -30.8% |
| Income Tax | $53K | — |
| Net Income | -$157.4M | -30.8% |
| EPS (Basic) | -$2.91 | +35.0% |
| EPS (Diluted) | -$2.91 | +35.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $115.4M | +79.4% |
| Short-term Investments | $439.4M | +48.4% |
| Current Assets | $563.2M | +53.4% |
| Total Assets | $679.2M | +76.8% |
| Current Liabilities | $35.1M | +59.3% |
| Total Liabilities | $128.3M | +379.2% |
| Stockholders' Equity | $550.9M | +54.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$122.3M | -57.1% |
| Capital Expenditures | $13.2M | +203.6% |
| Investing Cash Flow | -$156.0M | +34.8% |
| Financing Cash Flow | $329.0M | -12.8% |
| Free Cash Flow | -$135.6M | -64.8% |